Review
doi: 10.1017/erm.2012.4.
FGFR3 targeting strategies for achondroplasia
Affiliations
- PMID: 22559284
- DOI: 10.1017/erm.2012.4
Item in Clipboard
Review
FGFR3 targeting strategies for achondroplasia
Expert Rev Mol Med.
.
Abstract
Mutations that exaggerate signalling of the receptor tyrosine kinase fibroblast growth factor receptor 3 (FGFR3) give rise to achondroplasia, the most common form of dwarfism in humans. Here we review the clinical features, genetic aspects and molecular pathogenesis of achondroplasia and examine several therapeutic strategies designed to target the mutant receptor or its signalling pathways, including the use of kinase inhibitors, blocking antibodies, physiologic antagonists, RNAi and chaperone inhibitors. We conclude by discussing the challenges of treating growth plate disorders in children.
Similar articles
-
Effect of PPADS on achondroplasic chondrocytes: inhibition of FGF receptor type 3 over-activity.Eur J Pharmacol. 2008 Apr 14;584(1):72-7. doi: 10.1016/j.ejphar.2008.02.002. Epub 2008 Feb 12. Eur J Pharmacol. 2008. PMID: 18336810
-
Achondroplasia: pathogenesis and implications for future treatment.Curr Opin Pediatr. 2010 Aug;22(4):516-23. doi: 10.1097/MOP.0b013e32833b7a69. Curr Opin Pediatr. 2010. PMID: 20601886 Review.
-
[Cytokines in bone diseases. FGF receptor signaling and achondroplasia/hypochondroplasia].Clin Calcium. 2010 Oct;20(10):1490-6. Clin Calcium. 2010. PMID: 20890030 Review. Japanese.
-
Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.EMBO J. 1996 Feb 1;15(3):520-7. EMBO J. 1996. PMID: 8599935 Free PMC article.
-
Mutant FGFR3 associated with SADDAN disease causes cytoskeleton disorganization through PLCγ1/Src-mediated paxillin hyperphosphorylation.Int J Biochem Cell Biol. 2018 Feb;95:17-26. doi: 10.1016/j.biocel.2017.12.008. Epub 2017 Dec 11. Int J Biochem Cell Biol. 2018. PMID: 29242050
Cited by
-
Impairment of the transition from proliferative stage to prehypertrophic stage in chondrogenic differentiation of human induced pluripotent stem cells harboring the causative mutation of achondroplasia in fibroblast growth factor receptor 3.Regen Ther. 2017 Jan 26;6:15-20. doi: 10.1016/j.reth.2016.11.002. eCollection 2017 Jun. Regen Ther. 2017. PMID: 30271835 Free PMC article.
-
Molecular therapeutic strategies for FGFR3 gene-related skeletal dysplasia.J Mol Med (Berl). 2017 Dec;95(12):1303-1313. doi: 10.1007/s00109-017-1602-9. Epub 2017 Oct 23. J Mol Med (Berl). 2017. PMID: 29063142 Review.
-
Height matters-from monogenic disorders to normal variation.Nat Rev Endocrinol. 2013 Mar;9(3):171-7. doi: 10.1038/nrendo.2012.251. Epub 2013 Jan 22. Nat Rev Endocrinol. 2013. PMID: 23337954 Review.
-
FGF signaling in the osteoprogenitor lineage non-autonomously regulates postnatal chondrocyte proliferation and skeletal growth.Development. 2016 May 15;143(10):1811-22. doi: 10.1242/dev.131722. Epub 2016 Apr 6. Development. 2016. PMID: 27052727 Free PMC article.
-
Fibroblast growth factor signaling in skeletal development and disease.Genes Dev. 2015 Jul 15;29(14):1463-86. doi: 10.1101/gad.266551.115. Genes Dev. 2015. PMID: 26220993 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
